Junfeng Zhao

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.

|Apr 18, 2025
Nomogram based on computed tomography radiomics features and clinicopathological factors to predict the prognosis of patients with non-small cell lung cancer receiving immune checkpoint inhibitor rechallenge.

Junfeng Zhao, Ying Li, Ruyue Li

|Feb 24, 2024
Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components.

Ying Li, Junfeng Zhao, Ying Zhao

|Nov 29, 2023
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis.

Junfeng Zhao, Shaoyu Hao, Ying Li

|Nov 29, 2023
Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score Matching.

Dan Han, Jing Tian, Junfeng Zhao

|Aug 14, 2023
Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study.

Junfeng Zhao, Shaoyu Hao, Jing Tian

Pageof 1

Frequent Collaborators

2 joint publications

Dan Han

2 joint publications

Yintao Li

1 joint publications

Xiaoman Liu

1 joint publications

Ying Li